Focus your product strategy like never before
With so much riding on successfully managing the lifecycle of a product, failure is not an option. Having a precise understanding of the clinical marketplace, especially in more complex disease areas, can be the difference between a blockbuster and a lemon.
Iris integrates prescription, lab, payer, and patient-level data to give you richer insights than anywhere else. Optimize your commercial strategy, analyze competitive market share, and identify the key decision makers essential for driving therapy adoption.
And keeping tabs on brand performance has never been easier. Our post-launch surveillance capabilities give you the visibility you need to monitor and adapt to the changing needs of clinicians and patients.
The Iris Advantage:
Identify the healthcare providers who are actively treating eligible patients and having the biggest impact on standards of care in your therapeutic area
Analyze market share by the number of actual patients within a given indication vs. just the number of treatments prescribed
Understand key metrics for product performance, including competitive share, changes in Rx volume, patient eligibility, and prescribing behaviors
Monitor market changes post-launch to identify new opportunities to improve HCP utilization and find new, relevant sales regions and clinicians to target
Iris in Action:
Pre-Launch PlanningConfidently forecast brand potential. Analyze HCOs and HCPs by patient volume, prescribing patterns, patients on competitive therapies, and geographies
Messaging DevelopmentImprove the timeliness and relevance of your HCP communications by leveraging rich clinical profiling data, including specific treatment information
Competitive BenchmarkingUnderstand and combat churn using accurate analyses of HCPs’ adoption profiles
Sales Force OptimizationClose the loop on your sales strategy by understanding where best to allocate resources based on HCP profiles
Post-Launch MonitoringKnow how well your programs are performing. Track changes in market share at territory, regional, and national levels
Real Results That Make a Real Difference
With Iris, we saw 30% more disease burden than we did before. We were able to add 250 new accounts and deepen our engagement by 20%.
I’d never launch a product without Iris again. It provides the most complete view of clinical encounters and enables us to precisely target the right HCPs and patients for our therapy.
Since we started using Iris, we’ve been able to more accurately align our sales force to the right territories. It’s been a game-changer.